Abstract
The application of RNA interference (RNAi) to mammalian systems has the potential to revolutionize genetics and produce novel therapies. Here we investigate whether RNAi applied to a well-characterized gene can stably suppress gene expression in hematopoietic stem cells and produce detectable phenotypes in mice. Deletion of the Trp53 tumor suppressor gene greatly accelerates Myc-induced lymphomagenesis, resulting in highly disseminated disease1,2. To determine whether RNAi suppression of Trp53 could produce a similar phenotype, we introduced several Trp53 short hairpin RNAs (shRNAs) into hematopoietic stem cells derived from Eμ-Myc transgenic mice, and monitored tumor onset and overall pathology in lethally irradiated recipients. Different Trp53 shRNAs produced distinct phenotypes in vivo, ranging from benign lymphoid hyperplasias to highly disseminated lymphomas that paralleled Trp53−/− lymphomagenesis in the Eμ-Myc mouse. In all cases, the severity and type of disease correlated with the extent to which specific shRNAs inhibited p53 activity. Therefore, RNAi can stably suppress gene expression in stem cells and reconstituted organs derived from those cells. In addition, intrinsic differences between individual shRNA expression vectors targeting the same gene can be used to create an 'epi-allelic series' for dissecting gene function in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schmitt, C.A., McCurrach, M.E., de Stanchina, E., Wallace-Brodeur, R.R. & Lowe, S.W. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13, 2670–2677 (1999).
Schmitt, C.A. et al. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1, 289–298 (2002).
Hannon, G.J. RNA interference. Nature 418, 244–251 (2002).
Knight, S.W. & Bass, B.L. A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Science 293, 2269–2271 (2001).
Ketting, R.F. et al. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15, 2654–2659 (2001).
Hutvagner, G. et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834–838 (2001).
Grishok, A. et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106, 23–34 (2001).
Paddison, P.J. & Hannon, G.J. RNA interference: the new somatic cell genetics? Cancer Cell 2, 17–23 (2002).
Attardi, L.D. & Jacks, T. The role of p53 in tumour suppression: lessons from mouse models. Cell. Mol. Life Sci. 55, 48–63 (1999).
Evan, G.I. & Vousden, K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342–348 (2001).
Adams, J.M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533–538 (1985).
Zilfou, J.T., Hoffman, W.H., Sank, M., George, D.L. & Murphy, M. The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation. Mol. Cell. Biol. 21, 3974–3985 (2001).
McCurrach, M.E. & Lowe, S.W. Methods for studying pro- and antiapoptotic genes in nonimmortal cells. Methods Cell Biol. 66, 197–227 (2001).
Di Cristofano, A., De Acetis, M., Koff, A., Cordon-Cardo, C. & Pandolfi, P.P. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat. Genet. 27, 222–224 (2001).
Acknowledgements
We thank J. Adams and T. Jacks for providing mice, and C. Rosenthal, M. E. Dudas, and M. S. Jiao for invaluable technical assistance. P.J.P. is an Arnold and Mabel Beckman Fellow of the Watson School of Biological Sciences. G.J.H. is a Rita Allen Foundation Scholar and is supported by an Innovator award from the U.S. Army Breast Cancer Research Program. This work was supported by US National Cancer Institute (NCI) postdoctoral training grants (M.T.H. and J.T.Z.), program project grants (C.C.C., G.J.H. and S.W.L.) from the NCI, and a generous gift from the Ann L. and Herbert J. Siegel Philanthropic Fund.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Hemann, M., Fridman, J., Zilfou, J. et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet 33, 396–400 (2003). https://doi.org/10.1038/ng1091
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1091
This article is cited by
-
c-Myc inhibits LAPTM5 expression in B-cell lymphomas
Annals of Hematology (2023)
-
Partial p53 reactivation is sufficient to induce cancer regression
Journal of Experimental & Clinical Cancer Research (2022)
-
APR-246 triggers ferritinophagy and ferroptosis of diffuse large B-cell lymphoma cells with distinct TP53 mutations
Leukemia (2022)
-
New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines
BMC Biotechnology (2019)
-
An inducible long noncoding RNA amplifies DNA damage signaling
Nature Genetics (2016)